bf/NYSE:RMD_icon.jpeg

COM:RESMED

ResMed

  • Stock

USD

Last Close

243.60

22/11 21:00

Market Cap

28.25B

Beta: -

Volume Today

551.25K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Jun '14
Jun '15
Jun '16
Jun '17
Jun '18
Jun '19
Jun '20
Jun '21
Jun '22
Jun '23
Jun '24
average inventory
155.63M
-
206.14M
32.45%
235.66M
14.32%
246.39M
4.55%
268.51M
8.98%
309.17M
15.14%
383.28M
23.97%
436.97M
14.01%
600.47M
37.42%
870.96M
45.05%
910.13M
4.50%
average payables
73.05M
-
83.26M
13.98%
86.84M
4.30%
92.67M
6.71%
92.74M
0.08%
104.22M
12.38%
125.76M
20.66%
136.90M
8.86%
148.63M
8.57%
155.00M
4.29%
194.24M
25.32%
average receivables
338.97M
-
361.08M
6.52%
372.33M
3.11%
416.31M
11.81%
467.11M
12.20%
506.08M
8.34%
501.56M
0.89%
544.47M
8.55%
595.12M
9.30%
640.43M
7.61%
771.09M
20.40%
book value per share
12.43
-
11.30
9.08%
12.09
6.95%
13.87
14.75%
14.42
4.00%
14.48
0.40%
17.30
19.48%
19.86
14.79%
23.01
15.86%
28.14
22.30%
33.08
17.57%
capex per share
-0.57
-
-0.51
10.72%
-0.48
5.57%
-0.51
4.54%
-0.50
1.01%
-0.54
7.97%
-0.73
35.81%
-0.80
9.54%
-1.07
32.87%
-0.91
14.53%
0.78
185.56%
capex to depreciation
-1.10
-
-0.98
10.87%
-0.78
20.69%
-0.64
18.40%
-0.60
6.53%
-0.51
13.90%
-0.58
13.88%
-0.61
4.44%
-0.80
31.96%
-0.68
15.74%
0.39
157.27%
capex to operating cash flow
-0.21
-
-0.19
9.48%
-0.12
34.07%
-0.17
39.45%
-0.14
18.04%
-0.17
19.08%
-0.13
21.62%
-0.16
20.09%
-0.44
180.22%
-0.19
56.50%
0.08
142.41%
capex to revenue
-0.05
-
-0.04
17.90%
-0.04
13.91%
-0.03
6.25%
-0.03
11.71%
-0.03
2.83%
-0.04
20.74%
-0.04
2.01%
-0.04
19.33%
-0.03
27.24%
0.02
177.26%
cash per share
6.40
-
5.11
20.24%
5.22
2.14%
5.81
11.48%
1.32
77.27%
1.03
22.22%
3.21
212.12%
2.03
36.67%
1.87
7.78%
1.55
17.14%
1.62
4.41%
days of inventory on hand
106.83
-
134.98
26.36%
106.09
21.40%
113.22
6.72%
100.28
11.43%
119.27
18.94%
122.80
2.96%
122.87
0.06%
174.75
42.23%
195.08
11.63%
145.48
25.42%
days payables outstanding
55.15
-
44.35
19.59%
43.76
1.35%
39.14
10.54%
34.60
11.60%
39.48
14.08%
39.99
1.31%
37.10
7.23%
37.41
0.83%
29.47
21.23%
42.06
42.74%
days sales outstanding
84.41
-
78.82
6.62%
75.85
3.78%
79.57
4.90%
75.44
5.19%
74.00
1.90%
58.59
20.83%
70.14
19.71%
58.75
16.23%
60.93
3.70%
65.23
7.06%
debt to assets
0.13
-
0.21
61.24%
0.36
75.52%
0.37
3.44%
0.09
75.37%
0.31
236.80%
0.28
8.46%
0.17
40.73%
0.18
7.26%
0.23
29.96%
0.11
54.45%
debt to equity
0.17
-
0.28
65.24%
0.69
145.26%
0.66
4.81%
0.14
79.29%
0.61
348.65%
0.52
15.16%
0.28
47.14%
0.27
0.74%
0.38
40.12%
0.15
60.63%
dividend yield
0.02
-
0.02
0.52%
0.02
4.53%
0.02
10.71%
0.01
20.31%
0.01
11.40%
0.01
32.05%
0.01
22.08%
0.01
26.60%
0.01
0.52%
0.01
27.54%
earnings yield
0.05
-
0.04
7.54%
0.04
10.83%
0.03
21.76%
0.02
31.37%
0.02
7.04%
0.02
1.80%
0.01
40.95%
0.03
92.17%
0.03
9.96%
0.04
32.72%
enterprise value
6.56B
-
7.50B
14.39%
9.31B
24.12%
11.26B
20.98%
14.88B
32.10%
18.84B
26.58%
28.55B
51.57%
36.32B
27.22%
31.26B
13.92%
33.42B
6.90%
28.12B
15.86%
enterprise value over ebitda
15.34
-
15.18
1.07%
17.22
13.50%
18.78
9.03%
21.30
13.41%
22.33
4.84%
28.84
29.17%
32.65
13.19%
26.18
19.80%
24.95
4.71%
16.61
33.44%
ev to operating cash flow
16.76
-
19.58
16.80%
16.99
13.20%
27.21
60.10%
29.46
8.30%
41.03
39.26%
35.59
13.27%
49.30
38.54%
89.03
80.59%
48.20
45.86%
20.07
58.37%
ev to sales
4.22
-
4.47
5.95%
5.06
13.33%
5.45
7.63%
6.36
16.66%
7.23
13.64%
9.65
33.61%
11.36
17.68%
8.74
23.10%
7.91
9.43%
6.00
24.16%
free cash flow per share
2.19
-
2.22
1.08%
3.42
54.51%
2.42
29.21%
3.04
25.32%
2.67
12.17%
4.82
80.87%
4.27
11.57%
1.34
68.69%
3.81
185.30%
8.75
129.60%
free cash flow yield
0.04
-
0.04
9.21%
0.05
37.74%
0.03
42.52%
0.03
5.79%
0.02
26.50%
0.03
16.59%
0.02
31.13%
0.01
63.18%
0.02
173.71%
0.05
168.36%
graham net net
4.63
-
3.67
20.76%
-3.09
184.28%
-1.52
51.02%
-2.24
47.50%
-9.20
311.74%
-7.36
20.00%
-5.90
19.81%
-4.50
23.76%
-9.31
106.81%
-4.97
46.60%
graham number
26.12
-
25.27
3.26%
26.14
3.43%
27.49
5.15%
26.78
2.56%
30.35
13.31%
40.95
34.92%
38.20
6.71%
52.56
37.60%
62.23
18.39%
71.90
15.54%
income quality
1.13
-
1.09
4.18%
1.55
43.19%
1.21
22.20%
1.60
32.29%
1.13
29.10%
1.29
13.74%
1.55
20.31%
0.45
70.98%
0.77
71.46%
1.37
77.69%
intangibles to total assets
0.14
-
0.14
0.62%
0.42
192.51%
0.38
8.28%
0.42
9.57%
0.58
38.15%
0.51
11.96%
0.49
3.72%
0.45
8.74%
0.49
9.87%
0
100%
interest coverage
66.09
-
70.83
7.16%
38.28
45.95%
15.08
60.60%
19.11
26.72%
16.02
16.16%
20.05
25.16%
37.67
87.86%
-44.83
219.01%
-23.89
46.71%
-30.58
28.00%
interest debt per share
2.17
-
3.24
49.14%
8.46
161.43%
9.35
10.55%
2.17
76.79%
9.13
320.85%
9.28
1.63%
5.63
39.37%
6.13
8.92%
10.44
70.37%
4.67
55.27%
inventory turnover
3.42
-
2.70
20.86%
3.44
27.23%
3.22
6.30%
3.64
12.91%
3.06
15.92%
2.97
2.87%
2.97
0.06%
2.09
29.69%
1.87
10.42%
2.51
34.09%
invested capital
0.17
-
0.28
65.24%
0.69
145.26%
0.66
4.81%
0.14
79.29%
0.61
348.65%
0.52
15.16%
0.28
47.14%
0.27
0.74%
0.38
40.12%
2.15B
561,022,484,603.54%
market cap
7.16B
-
7.92B
10.55%
8.87B
11.99%
11.01B
24.14%
14.79B
34.34%
17.71B
19.77%
27.71B
56.47%
35.82B
29.26%
30.62B
14.52%
32.07B
4.73%
27.48B
14.29%
net current asset value
953.50M
-
847.23M
11.14%
-144.38M
117.04%
135.78M
194.04%
60.77M
55.24%
-890.12M
1,564.64%
-566.89M
36.31%
-267.69M
52.78%
196.38M
173.36%
-253.97M
229.33%
349.37M
237.56%
net debt to ebitda
-1.42
-
-0.84
40.44%
0.82
197.35%
0.43
47.85%
0.13
68.98%
1.33
903.48%
0.84
36.59%
0.45
46.96%
0.54
20.35%
1.01
87.20%
0.38
62.81%
net income per share
2.44
-
2.51
2.94%
2.51
0.03%
2.42
3.64%
2.21
8.71%
2.83
27.89%
4.31
52.35%
3.27
24.19%
5.34
63.42%
6.12
14.61%
6.94
13.55%
operating cash flow per share
2.77
-
2.73
1.37%
3.91
43.23%
2.93
25.03%
3.54
20.77%
3.21
9.32%
5.56
73.28%
5.07
8.79%
2.40
52.58%
4.72
96.50%
9.53
101.76%
payables turnover
6.62
-
8.23
24.36%
8.34
1.36%
9.32
11.78%
10.55
13.12%
9.25
12.34%
9.13
1.29%
9.84
7.80%
9.76
0.82%
12.39
26.94%
8.68
29.94%
receivables turnover
4.32
-
4.63
7.08%
4.81
3.92%
4.59
4.67%
4.84
5.47%
4.93
1.94%
6.23
26.31%
5.20
16.47%
6.21
19.38%
5.99
3.57%
5.60
6.59%
research and ddevelopement to revenue
0.08
-
0.07
10.02%
0.06
5.68%
0.07
8.32%
0.07
5.16%
0.07
4.54%
0.07
1.46%
0.07
3.19%
0.07
0.56%
0.07
3.89%
0.07
3.64%
return on tangible assets
0.17
-
0.19
10.59%
0.19
1.56%
0.16
13.84%
0.18
10.95%
0.23
31.95%
0.28
18.15%
0.20
28.71%
0.28
40.57%
0.26
5.52%
0.15
43.24%
revenue per share
10.99
-
11.95
8.74%
13.11
9.69%
14.62
11.51%
16.39
12.12%
18.21
11.11%
20.49
12.48%
22.00
7.38%
24.50
11.35%
28.77
17.46%
31.87
10.75%
roe
0.20
-
0.22
13.21%
0.21
6.47%
0.17
16.02%
0.15
12.22%
0.20
27.39%
0.25
27.51%
0.16
33.95%
0.23
41.04%
0.22
6.29%
0.21
3.42%
roic
0.16
-
0.16
3.26%
0.12
26.35%
0.11
10.74%
0.14
31.02%
0.14
3.59%
0.18
29.65%
0.13
27.44%
0.18
44.47%
0.16
14.13%
0.20
27.85%
sales general and administrative to revenue
0.29
-
0.29
1.58%
0.27
6.89%
0.27
0.98%
0.26
4.29%
shareholders equity per share
12.43
-
11.30
9.08%
12.09
6.95%
13.87
14.75%
14.42
4.00%
14.48
0.40%
17.30
19.48%
19.86
14.79%
23.01
15.86%
28.14
22.30%
33.08
17.57%
stock based compensation to revenue
0.03
-
0.03
1.99%
0.03
11.45%
0.02
11.96%
0.02
6.90%
0.02
3.43%
0.02
2.56%
0.02
2.73%
0.02
8.80%
0.02
7.63%
0.02
1.59%
tangible asset value
1.42B
-
1.28B
10.38%
335.78M
73.68%
633.59M
88.69%
774.85M
22.30%
-306.21M
139.52%
158.53M
151.77%
565.20M
256.51%
1.08B
90.79%
807.26M
25.14%
4.86B
502.54%
tangible book value per share
10.06
-
9.08
9.74%
2.39
73.64%
4.48
87.20%
5.43
21.09%
-2.14
139.42%
1.10
151.33%
3.89
254.12%
7.38
89.81%
5.50
25.50%
33.08
501.48%
working capital
1.29B
-
1.18B
8.53%
781.17M
33.63%
1.28B
64.35%
554.47M
56.81%
589.38M
6.30%
920.70M
56.22%
662.99M
27.99%
1.24B
87.36%
1.61B
29.55%
1.45B
10.08%

All numbers in USD (except ratios and percentages)